Explore 3 Stock Ideas & Industry Insights Download Free Report

Perimeter Medical Imaging AI Inc

Company price
0.103 USD -0.02 ( 14.17%)
Last update at 2026-11-06T17:48:00Z
VOLUME
445000
Market Cap
52.93M

Momentum Score

…

Perimeter Medical Imaging AI, Inc., a medical technology company, develops and commercializes advanced imaging tools that allow surgeons, radiologists, and pathologists to visualize microscopic tissue structures during a clinical procedure. The company offers an optical coherence tomography (OCT) imaging system provides clinicians with cross-sectional of tissues down to 2 mm dept. This OCT imaging system consists of S-series OCT and B-series OCT. It also offers ImgAssist, an artificial intelligence technology that enhances the efficiency of image review and be an additional powerful tool when combined with Perimeter OCT to aid physicians with real-time margin visualization and assessment to improve surgical outcomes for patients and reducing the likelihood of needing additional surgeries. In addition, the company offers proprietary image library and consumable specimen containers to hospitals and cancer surgery centers. The company was founded in 2013 and is headquartered in Toronto, Canada.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
0.10
Low
0.11
High
52 Week Price Range
0.54
Low
1.50
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High

Key Metrics*

Previous Close
0.12
Dividend Yield
-
Revenue TTM
0.63M
Revenue Per Share
0.01
Gross Profit TTM
-0.74M
Debt / Equity
0.01
ROE
-51.67%
Net Debt
-28.11M
ROCE
-60.71%
Diluted EPS TTM
-0.19

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Income before tax -9.91M -16.65M -7.89M -10.34M -
Net income -3.59M -16.76M -8.00M -10.50M -
Selling general administrative 5.45M 7.89M 8.84M 7.51M -
Selling and marketing expenses 4.84M 3.67M 0.12M 0.04M -
Gross profit 0.10M 0.01M - - -
Reconciled depreciation 0.80M 0.09M 0.05M 0.05M -
Ebit -16.12M -16.05M -11.67M -13.02M -5.89M
Ebitda -15.32M -15.95M -11.62M -12.97M -
Depreciation and amortization 0.80M 0.09M 0.05M 0.05M -
Operating income -16.12M -16.05M -11.67M -13.02M -
Other operating expenses 16.25M 16.07M 10.06M 8.56M 0.31M
Interest expense 0.10M 0.11M 0.12M 0.16M 0.00M
Tax provision 0.00M 0.00M 0.00M 0.00M -
Interest income - 0.01M 0.01M 0.00M -
Net interest income -0.10M -0.10M -1.72M -4.61M -
Income tax expense -6.32M 0.11M 0.12M 0.16M -
Total revenue 0.13M 0.01M 0.00M 0.00M -
Total operating expenses 16.22M 16.06M 10.06M 8.56M -
Cost of revenue 0.03M 0.01M - - -
Total other income expense net 6.22M -0.60M 3.78M 2.68M -
Net income from continuing ops -9.91M -16.65M -7.89M -10.34M -
Net income applicable to common shares - - -7.89M -10.34M -6.50M
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Total assets 34.60M 9.98M 13.16M 2.55M -
Other current assets 1.04M 1.25M - - -
Total liab 8.49M 2.56M 2.40M 19.03M -
Total stockholder equity 26.11M 7.42M 10.76M -16.47M -
Other current liab 7.79M 1.85M 1.21M 2.36M 2.17M
Common stock 80.84M 62.47M 48.50M 17.80M 13.54M
Capital stock 80.84M 62.47M 48.50M 17.80M -
Retained earnings -59.32M -63.98M -47.33M -39.44M -29.10M
Other liab - - 0.27M 0.28M 0.42M
Cash 28.44M 4.72M 10.03M 1.21M -
Total current liabilities 8.04M 2.15M 1.82M 18.54M 15.05M
Current deferred revenue 0.10M 0.11M 0.52M 0.14M -
Net debt -28.11M -4.28M -9.62M 13.00M -
Short term debt 0.15M 0.18M 0.09M 14.01M -
Short long term debt 0.11M 0.13M 0.05M 13.99M -
Short long term debt total 0.33M 0.44M 0.40M 14.21M -
Other stockholder equity 6.64M 8.83M 9.40M 5.17M -
Property plant equipment - - 0.08M 0.07M 0.04M
Total current assets 31.50M 7.74M 13.07M 2.48M 2.90M
Net tangible assets - - 10.76M -16.48M -12.91M
Short term investments 0.00M 0.42M 1.67M 0.00M -
Net receivables 1.98M 1.33M 0.60M 1.01M 0.85M
Long term debt 0.01M 0.16M 0.29M 0.20M -
Inventory 0.04M 0.01M - - -
Accounts payable - - 1.21M 2.03M 0.63M
Accumulated other comprehensive income -2.04M 0.10M 0.18M - -
Non current assets total 3.10M 2.25M 0.09M 0.07M -
Capital lease obligations 0.21M 0.15M 0.06M 0.02M -
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Investments -1.75M -1.45M 6.33M 6.33M 6.33M
Change to liabilities 0.00M -0.91M -0.16M 1.06M 0.75M
Total cashflows from investing activities - - 7.24M -0.05M -0.05M
Net borrowings - - -0.14M 1.11M -0.03M
Total cash from financing activities 40.28M 10.06M 9.84M 5.20M -0.03M
Change to operating activities - -0.49M -0.51M -0.05M -0.02M
Net income -9.91M -16.65M -7.89M -10.34M -6.50M
Change in cash 24.72M -5.31M 8.81M -0.64M -4.17M
Begin period cash flow 3.72M 10.03M 1.21M 1.85M -
End period cash flow 28.44M 4.72M 10.03M 1.21M 1.85M
Total cash from operating activities -11.87M -13.91M -8.26M -5.79M -4.09M
Issuance of capital stock 38.14M 0.00M 9.41M 4.08M -
Depreciation 0.80M 0.09M 0.05M 0.05M 0.03M
Change to inventory -0.04M -0.01M - - -
Change to account receivables -0.07M 0.27M -0.26M 0.19M -0.18M
Other cashflows from financing activities 2.37M 10.26M 0.57M 1.83M -0.31M
Change to netincome - - 0.50M 3.07M 1.84M
Capital expenditures 1.99M 2.12M 0.00M 0.05M 0.05M
Change in working capital -0.23M 0.41M -0.94M 1.21M -
Stock based compensation 1.52M 3.13M 2.25M 1.32M -
Other non cash items -4.06M -0.90M -1.84M 1.98M -
Free cash flow -13.86M -16.03M -8.26M -5.83M -

Peer Comparison*

Sector: Healthcare Industry: Medical Devices

Stock Name
Change
(USD)
Price
(USD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
PYNKF
Perimeter Medical Imaging AI Inc
-0.02
14.17%
0.10 - - 81.69 2.80 83.68 -2.90
ABT
Abbott Laboratories
-0.03
0.03%
109.93 25.97 17.24 3.57 3.20 3.81 16.75
MDT
Medtronic PLC
-3.04
2.90%
101.80 26.60 15.87 3.35 2.08 3.90 14.12
SYK
Stryker Corporation
-9.21
2.75%
325.87 29.23 16.86 4.18 4.51 4.63 17.16
SEMHF
Siemens Healthineers AG
-2.15
4.12%
49.85 39.57 21.32 3.01 3.29 2.95 16.92

Profile*

Perimeter Medical Imaging AI Inc

Perimeter Medical Imaging AI, Inc., a medical technology company, develops and commercializes advanced imaging tools that allow surgeons, radiologists, and pathologists to visualize microscopic tissue structures during a clinical procedure. The company offers an optical coherence tomography (OCT) imaging system provides clinicians with cross-sectional of tissues down to 2 mm dept. This OCT imaging system consists of S-series OCT and B-series OCT. It also offers ImgAssist, an artificial intelligence technology that enhances the efficiency of image review and be an additional powerful tool when combined with Perimeter OCT to aid physicians with real-time margin visualization and assessment to improve surgical outcomes for patients and reducing the likelihood of needing additional surgeries. In addition, the company offers proprietary image library and consumable specimen containers to hospitals and cancer surgery centers. The company was founded in 2013 and is headquartered in Toronto, Canada.

359 Eastern Avenue, Toronto, ON, Canada, M4M 1B7

647 360 0302

Name Title Year Born
Mr. Jeremy Sobotta CEO, Pres & Director NA
Mr. Merle Thomas Boon Chief Operating Officer NA
Mr. Andrew Berkeley Co-Founder & Head of Bus. Devel. NA
Mr. Christopher K. Scott Chief Financial Officer 1970
Mr. Vladimir Pekar Head of AI Algorithm Devel. NA
Ms. Rochelle Keen Head of Clinical Research Programs NA
Mr. Steve Sapot Chief Commercial Officer NA

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Support

Hi! How can we help you today?

Loading…